Cargando…

Basic Design Considerations for Clinical Trials in Oncology

Detalles Bibliográficos
Autores principales:	Piantadosi, Steven, Saijo, Nagahiro, Tamura, Tomohide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918883/ https://www.ncbi.nlm.nih.gov/pubmed/1644658 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00124.x

Ejemplares similares

Guidelines for Analysis and Reporting of Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1993)

The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
por: Saijo, Nagahiro
Publicado: (2013)

Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting Toxicities
por: Tamura, Tomohide, et al.
Publicado: (1995)

CPT‐11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
por: Shimizu, Mikiko, et al.
Publicado: (2001)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Ethical considerations of neuro-oncology trial design in the era of precision medicine
por: Gupta, Saksham, et al.
Publicado: (2017)

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage
por: Isaacs, James, et al.
Publicado: (2022)

Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)

Highlights for ESMO 40: celebration review for lifetime achievement awards
por: Saijo, Nagahiro
Publicado: (2016)

Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials
por: Wei, Lai, et al.
Publicado: (2019)

Clinical considerations for the development of biosimilars in oncology
por: Socinski, Mark A, et al.
Publicado: (2015)

Present Status and Problems on Molecular Targeted Therapy of Cancer
por: Saijo, Nagahiro
Publicado: (2012)

Considerations for designing trials targeting muscle dysfunction in exercise oncology
por: Brooks, Alexander, et al.
Publicado: (2023)

Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs
por: Ohtsu, Atsushi, et al.
Publicado: (1989)

Reversal of Cisplatin Resistance by the 1,4‐Benzothiazepine Derivative, JTV‐519
por: Nakamura, Takashi, et al.
Publicado: (2001)

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
por: Hobbs, Brian P, et al.
Publicado: (2018)

New Considerations in the Design of Clinical Trials for Bone Metastases
por: Lemke, Madeline, et al.
Publicado: (2012)

Clinical trials : a methodologic perspective
por: Piantadosi, Steven
Publicado: (1997)

A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
por: Oshita, Fumihiro, et al.
Publicado: (1995)

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
por: Fournier, Christina N.
Publicado: (2022)

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
por: Foster, Jessica B., et al.
Publicado: (2023)

Lingual lymph nodes: Anatomy, clinical considerations, and oncological significance
por: Gvetadze, Shalva R, et al.
Publicado: (2020)

From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis
por: Li, Rou, et al.
Publicado: (2023)

Serial Measurement of Sister Chromatid Exchanges in the Peripheral Lymphocytes of Patients with Lung Cancer Receiving Chemotherapy in Relation to Bone Marrow Toxicity
por: Shinkai, Tetsu, et al.
Publicado: (1989)

A Bayesian Adaptive Design for Combination of Three Drugs in Cancer Phase I Clinical Trials
por: Tighiouart, Mourad, et al.
Publicado: (2016)

Design Considerations for Clinical Trials in Aphasia
por: Palmer, Rebecca
Publicado: (2020)

‘CLINICAL ONCOLOGY – BASIC PRINCIPLES AND PRACTICE’, 4TH EDITION
Publicado: (2011)

Study design considerations for irritable bowel syndrome clinical trials
por: Miller, Larry E.
Publicado: (2014)

Principles and practice of clinical trials
por: Piantadosi, Steven, et al.
Publicado: (2020)

Oncological considerations of skin-sparing mastectomy
por: Cunnick, GH, et al.
Publicado: (2006)

Considerations for Embedding Inclusive Research Principles in the Design and Execution of Clinical Trials
por: Peters, Ubong, et al.
Publicado: (2022)

Three Schedules of Recombinant Human Interleukin‐2 in the Treatment of Malignancy: Side Effects and Immunologic Effects in Relation to Serum Level
por: Sano, Tetsuro, et al.
Publicado: (1988)

Editorial: Cardiogenic Shock: Basic and Clinical Considerations
por: Acharya, Deepak, et al.
Publicado: (2021)

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma
por: Hoering, Antje, et al.
Publicado: (2017)

Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202
por: Sanuki-Fujimoto, Naoko, et al.
Publicado: (2009)

Pediatric Palliative Care in Oncology: Basic Principles
por: Benini, Franca, et al.
Publicado: (2022)

Clinical considerations for the design of PROTACs in cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2022)

Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D)
por: Sasaki, Yasutsuna, et al.
Publicado: (1990)

Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion
por: Tamura, Tomohide, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_sk897qif640an72gcsot1u6lls